Hormone therapy and stroke

Stanley J. Birge

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Available biochemical and clinical data are sufficiently compelling to recommend low dose or transdermal hormone therapy for the management of menopausal symptoms when possible. Women initiating low dose or transdermal hormone therapy are not at increased risk of cardiovascular disease, stroke, venous thrombotic disease, and breast cancer. Evidence suggests that these outcomes are favorably affected by low-dose hormone therapy and persist with continuation of therapy.

Original languageEnglish
Pages (from-to)581-591
Number of pages11
JournalClinical Obstetrics and Gynecology
Issue number3
StatePublished - Sep 2008


  • Hormone therapy
  • Menopause
  • Stroke


Dive into the research topics of 'Hormone therapy and stroke'. Together they form a unique fingerprint.

Cite this